Metropolitan Life Insurance Company (MetLife)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,766
| Closed | -$46.2K | – | 2842 |
|
|
2021
Q3 | $46.2K | Sell |
5,766
-5,494
| -49% | -$44.1K | ﹤0.01% | 2769 |
|
|
2021
Q2 | $128K | Buy |
+11,260
| New | +$128K | ﹤0.01% | 2462 |
|
|
2014
Q4 | – | Sell |
-191
| Closed | -$286K | – | 2676 |
|
|
2014
Q3 | $286K | Buy |
191
+4
| +2% | +$5.99K | ﹤0.01% | 2114 |
|
|
2014
Q2 | $256K | Buy |
187
+50
| +36% | +$68.4K | ﹤0.01% | 2330 |
|
|
2014
Q1 | $190K | Buy |
+137
| New | +$190K | ﹤0.01% | 2496 |
|
|
2013
Q3 | – | Sell |
-134
| Closed | -$147K | – | 2773 |
|
|
2013
Q2 | $147K | Buy |
+134
| New | +$147K | ﹤0.01% | 2561 |
|